BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7830979)

  • 1. The costs of mammography screening in New Zealand: evidence from the pilot programmes.
    Menon A; Devlin NJ; Richardson AK
    N Z Med J; 1994 Dec; 107(991):501-3. PubMed ID: 7830979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Counting the costs of mammography screening: first year results from the Sydney study.
    Gerard K; Salkeld G; Hall J
    Med J Aust; 1990 May; 152(9):466, 469-71. PubMed ID: 2381337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of urban and rural participants in the Otago-Southland pilot breast cancer screening programme.
    Richardson AK; Elwood JM; McNoe B; Bang E
    N Z Med J; 1994 Feb; 107(971):36-8. PubMed ID: 8302502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based breast cancer screening: policy advice for a New Zealand screening programme. Breast Cancer Screening Policy Advisory Group.
    N Z Med J; 1998 Apr; 111(1064):138-42. PubMed ID: 9612474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of the Otago-Southland Breast Cancer Screening Programme 1991-1996.
    Doyle TC; Elwood JM; Smale P; Berkeley BB; Blennerhassett JB; Miller AP; Chartres SM; Hunter MH; Packer SG; Pfeifer M
    N Z Med J; 1998 Oct; 111(1075):380-3. PubMed ID: 9830418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand.
    Szeto KL; Devlin NJ
    Health Policy; 1996 Nov; 38(2):101-15. PubMed ID: 10160378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
    Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
    Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
    Giorgi R; Reynaud J; Wait S; Seradour B
    Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographic screening for breast cancer: prospects for New Zealand.
    Skegg D; Paul C; Benson-Cooper D; Chetwynd J; Clarke A; Fitzgerald N; Gray A; St George I; Simpson A
    N Z Med J; 1988 Aug; 101(852):531-3. PubMed ID: 3045716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the costs of mammographic screening program in the city of Florence].
    Spagnolo G; Zappa M; Paci E; Giorgi D; Rosselli del Turco M
    Epidemiol Prev; 1995 Dec; 19(65):330-7. PubMed ID: 8852082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
    Olivotto IA; Kan L; Mates D; King S
    CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The cost of breast cancer screening in France].
    Wait S; Schaffer P; Séradour B; Guldenfels C; Gairard B; Morin F; Piana L
    J Radiol; 2000 Jul; 81(7):799-806. PubMed ID: 10915994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A workplace breast cancer screening program. Costs and components.
    Schrammel P; Griffiths RI; Griffiths CB
    AAOHN J; 1998 Nov; 46(11):523-9. PubMed ID: 9934000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme.
    Richardson A; Graham P; Brown T; Smale P; Cox B
    J Med Screen; 2004; 11(2):65-9. PubMed ID: 15153320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic analysis of outreach assessment clinics in breast screening programmes.
    van der Pol MM; Cairns JA; Gilbert FJ; Hendry PJ
    Int J Health Plann Manage; 1999; 14(1):57-67. PubMed ID: 10351680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness of mammography screening in Norway].
    Kåresen R; Bø JK; Haustveit S; Hervik A; Thoresen SO
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3553-9. PubMed ID: 10563171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.